Whitepaper:
E-Learning in pharmaceutical companies – flexible, efficient, and GMP-compliant
Introduction
Digitalization is fundamentally transforming employee training in the pharmaceutical industry. Today, companies face the challenge of training employees efficiently while complying with regulatory requirements such as the EU GMP Guidelines, the AMWHV, and Annex 11. Digital learning platforms offer new possibilities for this — from automated documentation to audit-compliant performance monitoring.
In our free white paper, you will discover how modern e-learning solutions can streamline training processes for your pharmaceutical training programmes using our performance-monitored, GAMP5-validated and audit-ready e-learning platform, OSIANTO, thereby supporting compliance and saving you time and money in the long term.
Download
Download the white paper for free now and learn how digital employee training can be implemented in pharmaceutical companies in an efficient, GMP-compliant, and audit-ready manner.
Frequently Asked Questions (FAQ):
Is the white paper free?
Yes, the download is available to you free of charge.
What challenges does the white paper address?
Many pharmaceutical companies face the same questions every day:
- How can employee training be documented in a GMP-compliant manner?
- What are the legal requirements for digital training?
- How can training processes be made more efficient?
- What are the advantages of a Learning Management System (LMS) compared to traditional face-to-face training?
- How can you ensure that your documentation is audit- and inspection-ready?
- What role do data protection, validation, and GAMP 5 play?
- How can existing HR or ERP systems be integrated?
What can you expect to find in the white paper?
Among other things, the white paper explains:
- how our modern learning management system, OSIANTO, simplifies your pharmaceutical training processes,
- regulatory framework related to EU GMP, AMWHV, and Annex 11,
- the benefits of digital staff training,
- typical use cases for OSIANTO in pharmaceutical companies,
- Features of OSIANTO,
- data protection and validation requirements,
- Best practices for implementing a learning management system, as well as
- recommendations for the successful implementation of digital training processes.
Who is this white paper intended for?
This white paper is intended specifically for:
- Pharmaceutical companies (manufacturers of active ingredients, contract manufacturers and medical device manufacturers)
- Companies that want to digitize their employee training programs
- Regulated service providers
- Qualified Person Responsible for Pharmacovigilance (QPPV) / Drug Safety Officer (DSO)
- Department of Drug Safety/Pharmacovigilance
- Quality Management (QM)
- Quality Assurance (QA)
- Compliance Officers
- GMP Representative
- HR and Training Managers
- Production Manager
Why is it worth downloading?
Anyone wishing to digitise training processes needs not only suitable software, but also an understanding of the regulatory requirements. This white paper shows how compliance, documentation and efficient staff training can be combined, and what benefits our modern learning management system, OSIANTO, offers in this regard.
These questions are explained in a practical manner in the white paper and answered using specific use cases.